Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles/doxorubicin encapsulated into DSPC/azobenzene liposomes

Based on

1 Articles
2016 Most recent source

Composition

1

2-(4-(2-hydroxyethyl)piperazin-1-yl)ethanesulfonic acid aqueous solution

Type Complex Compound
Formula
Role core
2

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 upconversion nanoparticles

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 core/shell UCNP phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles lipid-UCNP
Type Nano Material
Formula
Role loaded material
3

adriblastin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material
4

1,2-distearoyl-sn-glycero-3-phosphocholine/({4-[2-(4-dodecanamidophenyl)diazen-1-yl]phenyl}methyl)trimethylazanium bromide

Type Complex Compound
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
NIR laser-mediated drug release

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
HeLa cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • [(2R)-2,3-di(octadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
  • C28H43BrN4O
  1. TqKvVAWjUX5NLzjRkCf
  2. TFF1QG
  3. olF
Product

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles/doxorubicin encapsulated into DSPC/azobenzene liposomes

Size: not specified

Medium/Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • [(2R)-2,3-di(octadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
  • C28H43BrN4O
  1. 34yZzIDwOW5G1oqiQvE
  2. V2PCUJ
  3. EIj
Product

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles/doxorubicin encapsulated into DSPC/azobenzene liposomes

Size: not specified

Medium/Support: none

Method 3

Type: Physical formation
Source:
Starting materials
  • [(2R)-2,3-di(octadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
  • C28H43BrN4O
  1. DgF1uV09SN3v1pGPA4W
  2. Fm6Gpj
  3. tnz
Product

phosphatidylcholine modified oleic acid capped β-NaGdF4:Yb,Tm@β-NaGdF4 nanoparticles/doxorubicin encapsulated into DSPC/azobenzene liposomes

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial